cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa]
cyclosporine
RxCUI: 2055026
What the CMS Formulary Data Shows for cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa]
Per the CMS 2026 Part D formulary file, cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa] (RxNorm concept RXCUI 2055026, generic name cyclosporine) appears on 10 distinct formulary files spanning 149 Medicare Part D plan offerings - 2.9% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.2.
Real-world access to cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa] depends on utilization management as much as tier placement: 20% of covering formularies require prior authorization. 0% require step therapy. 30% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 492,479 Part D beneficiaries filled cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa] in 2023, with total plan-and-beneficiary spending of $1,501,664,198 and an average per-beneficiary annual cost of $3,049.19. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa] today.
Coverage Details
- Formularies covering
- 10
- Plans covering
- 149
- Coverage rate
- 2.9%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 20% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 30% of formularies
2023 Medicare Spending
- Beneficiaries
- 492,479
- Total spending
- $1,501,664,198
- Avg per beneficiary
- $3,049.19
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa] covered by Medicare Part D?
Yes, cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa] is covered by 149 Medicare Part D plans (2.9% of all Part D formularies).
What tier is cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa] on Medicare Part D plans?
cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa] averages Tier 3.2 across Part D plans, ranging from Tier 1 to Tier 4.
Does cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa] require prior authorization?
20% of Part D formularies require prior authorization for cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa]. Step therapy: 0%. Quantity limits: 30%.
How much does Medicare spend on cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa]?
In 2023, total Medicare Part D spending on cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa] was $1,501,664,198, covering 492,479 beneficiaries. The average spend per beneficiary was $3,049.19.
Read our methodology - how this data is sourced, computed, and verified.